- IBDEI1M2 ; ; 01-FEB-2022
- ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- Q:'DIFQR(358.4) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
- Q Q
- ;;^UTILITY(U,$J,358.4,354,0)
- ;;=CONSULTATIONS^3^35
- ;;^UTILITY(U,$J,358.4,355,0)
- ;;=ESOPHAGUS^4^36
- ;;^UTILITY(U,$J,358.4,356,0)
- ;;=COLON^3^36
- ;;^UTILITY(U,$J,358.4,357,0)
- ;;=LIVER^6^36
- ;;^UTILITY(U,$J,358.4,358,0)
- ;;=PANCREAS^8^36
- ;;^UTILITY(U,$J,358.4,359,0)
- ;;=SMALL INTESTINE^11^36
- ;;^UTILITY(U,$J,358.4,360,0)
- ;;=STOMACH^12^36
- ;;^UTILITY(U,$J,358.4,361,0)
- ;;=POST SURGERY STATES^9^36
- ;;^UTILITY(U,$J,358.4,362,0)
- ;;=SYMPTOMS^14^36
- ;;^UTILITY(U,$J,358.4,363,0)
- ;;=SCREENING^10^36
- ;;^UTILITY(U,$J,358.4,364,0)
- ;;=BILIARY^2^36
- ;;^UTILITY(U,$J,358.4,365,0)
- ;;=COMOBIDITIES^15^36
- ;;^UTILITY(U,$J,358.4,366,0)
- ;;=ANORECTAL^1^36
- ;;^UTILITY(U,$J,358.4,367,0)
- ;;=INFLAMMATORY BOWEL DISEASE^5^36
- ;;^UTILITY(U,$J,358.4,368,0)
- ;;=OTHER^7^36
- ;;^UTILITY(U,$J,358.4,369,0)
- ;;=SUICIDE IDEATIONS/ATTEMPTS^13^36
- ;;^UTILITY(U,$J,358.4,370,0)
- ;;=EGD^3^37
- ;;^UTILITY(U,$J,358.4,371,0)
- ;;=SMALL INTESTINE ENDOSCOPY^14^37
- ;;^UTILITY(U,$J,358.4,372,0)
- ;;=SIGMOIDOSCOPY^13^37
- ;;^UTILITY(U,$J,358.4,373,0)
- ;;=COLONOSCOPY^2^37
- ;;^UTILITY(U,$J,358.4,374,0)
- ;;=ERCP^4^37
- ;;^UTILITY(U,$J,358.4,375,0)
- ;;=G-TUBE^6^37
- ;;^UTILITY(U,$J,358.4,376,0)
- ;;=MISCELLANEOUS^9^37
- ;;^UTILITY(U,$J,358.4,377,0)
- ;;=IMMUNIZATION^7^37
- ;;^UTILITY(U,$J,358.4,378,0)
- ;;=MOTILITY^11^37
- ;;^UTILITY(U,$J,358.4,379,0)
- ;;=EUS^5^37
- ;;^UTILITY(U,$J,358.4,380,0)
- ;;=LIVER^8^37
- ;;^UTILITY(U,$J,358.4,381,0)
- ;;=MODERATE SEDATION^10^37
- ;;^UTILITY(U,$J,358.4,382,0)
- ;;=MOST COMMONLY USED^1^37
- ;;^UTILITY(U,$J,358.4,383,0)
- ;;=PROLONGED SERVICES^12^37
- ;;^UTILITY(U,$J,358.4,384,0)
- ;;=NEW PATIENT HOME VISIT^2^38
- ;;^UTILITY(U,$J,358.4,385,0)
- ;;=ESTAB PATIENT HOME VISIT^1^38
- ;;^UTILITY(U,$J,358.4,386,0)
- ;;=PC COMMON DIAGNOSES^1^39
- ;;^UTILITY(U,$J,358.4,387,0)
- ;;=ADMINISTRATIVE TOPICS^15^39
- ;;^UTILITY(U,$J,358.4,388,0)
- ;;=ANGINA^16^39
- ;;^UTILITY(U,$J,358.4,389,0)
- ;;=ATHEROSCLEROSIS^17^39
- ;;^UTILITY(U,$J,358.4,390,0)
- ;;=CARDIOVASCULAR^18^39
- ;;^UTILITY(U,$J,358.4,391,0)
- ;;=DERMATOLOGY^22^39
- ;;^UTILITY(U,$J,358.4,392,0)
- ;;=EAR DISORDERS^24^39
- ;;^UTILITY(U,$J,358.4,393,0)
- ;;=EENT^25^39
- ;;^UTILITY(U,$J,358.4,394,0)
- ;;=ENDOCRINE/METABOLIC^26^39
- ;;^UTILITY(U,$J,358.4,395,0)
- ;;=EYE DISORDERS^27^39
- ;;^UTILITY(U,$J,358.4,396,0)
- ;;=EYE INJURY^28^39
- ;;^UTILITY(U,$J,358.4,397,0)
- ;;=GASTROENTEROLOGY^29^39
- ;;^UTILITY(U,$J,358.4,398,0)
- ;;=GU/RENAL^30^39
- ;;^UTILITY(U,$J,358.4,399,0)
- ;;=HEADACHE^31^39
- ;;^UTILITY(U,$J,358.4,400,0)
- ;;=HEART VALVE DISEASE^32^39
- ;;^UTILITY(U,$J,358.4,401,0)
- ;;=HEMATOLOGY/ONCOLOGY^33^39
- ;;^UTILITY(U,$J,358.4,402,0)
- ;;=HISTORY OF ILLNESS^34^39
- ;;^UTILITY(U,$J,358.4,403,0)
- ;;=INFECTIOUS DISEASE^35^39
- ;;^UTILITY(U,$J,358.4,404,0)
- ;;=LIVER DISEASE^36^39
- ;;^UTILITY(U,$J,358.4,405,0)
- ;;=MENTAL HEALTH^38^39
- ;;^UTILITY(U,$J,358.4,406,0)
- ;;=MOVEMENT DISORDERS^39^39
- ;;^UTILITY(U,$J,358.4,407,0)
- ;;=MUSCULOSKELETAL^40^39
- ;;^UTILITY(U,$J,358.4,408,0)
- ;;=NEUROLOGY^41^39
- ;;^UTILITY(U,$J,358.4,409,0)
- ;;=PAIN^42^39
- ;;^UTILITY(U,$J,358.4,410,0)
- ;;=PREVENTIVE HEALTH^43^39
- ;;^UTILITY(U,$J,358.4,411,0)
- ;;=PULMONARY^44^39
- ;;^UTILITY(U,$J,358.4,412,0)
- ;;=SEXUAL TRAUMA^45^39
- ;;^UTILITY(U,$J,358.4,413,0)
- ;;=SIGNS,SYMPTOMS,CONDITIONS^46^39
- ;;^UTILITY(U,$J,358.4,414,0)
- ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^39
- ;;^UTILITY(U,$J,358.4,415,0)
- ;;=SUBSTANCE DISORDERS^48^39
- ;;^UTILITY(U,$J,358.4,416,0)
- ;;=VARICOSE VEINS^50^39
- --- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1M2 3779 printed Feb 18, 2025@23:37:43 Page 2
- IBDEI1M2 ; ; 01-FEB-2022
- +1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
- +2 if 'DIFQR(358.4)
- QUIT
- FOR I=1:2
- SET X=$TEXT(Q+I)
- if X=""
- QUIT
- SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
- SET X=$EXTRACT(X,4,999)
- if $ASCII(Y)=126
- SET I=I+1
- SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
- if $ASCII(Y)=61
- SET Y=$EXTRACT(Y,2,999)
- XECUTE NO
- IF '$TEST
- SET @X=Y
- Q QUIT
- +1 ;;^UTILITY(U,$J,358.4,354,0)
- +2 ;;=CONSULTATIONS^3^35
- +3 ;;^UTILITY(U,$J,358.4,355,0)
- +4 ;;=ESOPHAGUS^4^36
- +5 ;;^UTILITY(U,$J,358.4,356,0)
- +6 ;;=COLON^3^36
- +7 ;;^UTILITY(U,$J,358.4,357,0)
- +8 ;;=LIVER^6^36
- +9 ;;^UTILITY(U,$J,358.4,358,0)
- +10 ;;=PANCREAS^8^36
- +11 ;;^UTILITY(U,$J,358.4,359,0)
- +12 ;;=SMALL INTESTINE^11^36
- +13 ;;^UTILITY(U,$J,358.4,360,0)
- +14 ;;=STOMACH^12^36
- +15 ;;^UTILITY(U,$J,358.4,361,0)
- +16 ;;=POST SURGERY STATES^9^36
- +17 ;;^UTILITY(U,$J,358.4,362,0)
- +18 ;;=SYMPTOMS^14^36
- +19 ;;^UTILITY(U,$J,358.4,363,0)
- +20 ;;=SCREENING^10^36
- +21 ;;^UTILITY(U,$J,358.4,364,0)
- +22 ;;=BILIARY^2^36
- +23 ;;^UTILITY(U,$J,358.4,365,0)
- +24 ;;=COMOBIDITIES^15^36
- +25 ;;^UTILITY(U,$J,358.4,366,0)
- +26 ;;=ANORECTAL^1^36
- +27 ;;^UTILITY(U,$J,358.4,367,0)
- +28 ;;=INFLAMMATORY BOWEL DISEASE^5^36
- +29 ;;^UTILITY(U,$J,358.4,368,0)
- +30 ;;=OTHER^7^36
- +31 ;;^UTILITY(U,$J,358.4,369,0)
- +32 ;;=SUICIDE IDEATIONS/ATTEMPTS^13^36
- +33 ;;^UTILITY(U,$J,358.4,370,0)
- +34 ;;=EGD^3^37
- +35 ;;^UTILITY(U,$J,358.4,371,0)
- +36 ;;=SMALL INTESTINE ENDOSCOPY^14^37
- +37 ;;^UTILITY(U,$J,358.4,372,0)
- +38 ;;=SIGMOIDOSCOPY^13^37
- +39 ;;^UTILITY(U,$J,358.4,373,0)
- +40 ;;=COLONOSCOPY^2^37
- +41 ;;^UTILITY(U,$J,358.4,374,0)
- +42 ;;=ERCP^4^37
- +43 ;;^UTILITY(U,$J,358.4,375,0)
- +44 ;;=G-TUBE^6^37
- +45 ;;^UTILITY(U,$J,358.4,376,0)
- +46 ;;=MISCELLANEOUS^9^37
- +47 ;;^UTILITY(U,$J,358.4,377,0)
- +48 ;;=IMMUNIZATION^7^37
- +49 ;;^UTILITY(U,$J,358.4,378,0)
- +50 ;;=MOTILITY^11^37
- +51 ;;^UTILITY(U,$J,358.4,379,0)
- +52 ;;=EUS^5^37
- +53 ;;^UTILITY(U,$J,358.4,380,0)
- +54 ;;=LIVER^8^37
- +55 ;;^UTILITY(U,$J,358.4,381,0)
- +56 ;;=MODERATE SEDATION^10^37
- +57 ;;^UTILITY(U,$J,358.4,382,0)
- +58 ;;=MOST COMMONLY USED^1^37
- +59 ;;^UTILITY(U,$J,358.4,383,0)
- +60 ;;=PROLONGED SERVICES^12^37
- +61 ;;^UTILITY(U,$J,358.4,384,0)
- +62 ;;=NEW PATIENT HOME VISIT^2^38
- +63 ;;^UTILITY(U,$J,358.4,385,0)
- +64 ;;=ESTAB PATIENT HOME VISIT^1^38
- +65 ;;^UTILITY(U,$J,358.4,386,0)
- +66 ;;=PC COMMON DIAGNOSES^1^39
- +67 ;;^UTILITY(U,$J,358.4,387,0)
- +68 ;;=ADMINISTRATIVE TOPICS^15^39
- +69 ;;^UTILITY(U,$J,358.4,388,0)
- +70 ;;=ANGINA^16^39
- +71 ;;^UTILITY(U,$J,358.4,389,0)
- +72 ;;=ATHEROSCLEROSIS^17^39
- +73 ;;^UTILITY(U,$J,358.4,390,0)
- +74 ;;=CARDIOVASCULAR^18^39
- +75 ;;^UTILITY(U,$J,358.4,391,0)
- +76 ;;=DERMATOLOGY^22^39
- +77 ;;^UTILITY(U,$J,358.4,392,0)
- +78 ;;=EAR DISORDERS^24^39
- +79 ;;^UTILITY(U,$J,358.4,393,0)
- +80 ;;=EENT^25^39
- +81 ;;^UTILITY(U,$J,358.4,394,0)
- +82 ;;=ENDOCRINE/METABOLIC^26^39
- +83 ;;^UTILITY(U,$J,358.4,395,0)
- +84 ;;=EYE DISORDERS^27^39
- +85 ;;^UTILITY(U,$J,358.4,396,0)
- +86 ;;=EYE INJURY^28^39
- +87 ;;^UTILITY(U,$J,358.4,397,0)
- +88 ;;=GASTROENTEROLOGY^29^39
- +89 ;;^UTILITY(U,$J,358.4,398,0)
- +90 ;;=GU/RENAL^30^39
- +91 ;;^UTILITY(U,$J,358.4,399,0)
- +92 ;;=HEADACHE^31^39
- +93 ;;^UTILITY(U,$J,358.4,400,0)
- +94 ;;=HEART VALVE DISEASE^32^39
- +95 ;;^UTILITY(U,$J,358.4,401,0)
- +96 ;;=HEMATOLOGY/ONCOLOGY^33^39
- +97 ;;^UTILITY(U,$J,358.4,402,0)
- +98 ;;=HISTORY OF ILLNESS^34^39
- +99 ;;^UTILITY(U,$J,358.4,403,0)
- +100 ;;=INFECTIOUS DISEASE^35^39
- +101 ;;^UTILITY(U,$J,358.4,404,0)
- +102 ;;=LIVER DISEASE^36^39
- +103 ;;^UTILITY(U,$J,358.4,405,0)
- +104 ;;=MENTAL HEALTH^38^39
- +105 ;;^UTILITY(U,$J,358.4,406,0)
- +106 ;;=MOVEMENT DISORDERS^39^39
- +107 ;;^UTILITY(U,$J,358.4,407,0)
- +108 ;;=MUSCULOSKELETAL^40^39
- +109 ;;^UTILITY(U,$J,358.4,408,0)
- +110 ;;=NEUROLOGY^41^39
- +111 ;;^UTILITY(U,$J,358.4,409,0)
- +112 ;;=PAIN^42^39
- +113 ;;^UTILITY(U,$J,358.4,410,0)
- +114 ;;=PREVENTIVE HEALTH^43^39
- +115 ;;^UTILITY(U,$J,358.4,411,0)
- +116 ;;=PULMONARY^44^39
- +117 ;;^UTILITY(U,$J,358.4,412,0)
- +118 ;;=SEXUAL TRAUMA^45^39
- +119 ;;^UTILITY(U,$J,358.4,413,0)
- +120 ;;=SIGNS,SYMPTOMS,CONDITIONS^46^39
- +121 ;;^UTILITY(U,$J,358.4,414,0)
- +122 ;;=SPRAIN/STRAIN-INITIAL ENCOUNTER^47^39
- +123 ;;^UTILITY(U,$J,358.4,415,0)
- +124 ;;=SUBSTANCE DISORDERS^48^39
- +125 ;;^UTILITY(U,$J,358.4,416,0)
- +126 ;;=VARICOSE VEINS^50^39
